Lanean...
Therapeutic gene editing in CD34(+) hematopoietic progenitors from Fanconi anemia patients
Gene targeting constitutes a new step in the development of gene therapy for inherited diseases. Although previous studies have shown the feasibility of editing fibroblasts from Fanconi anemia (FA) patients, here we aimed at conducting therapeutic gene editing in clinically relevant cells, such as h...
Gorde:
| Argitaratua izan da: | EMBO Mol Med |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5666315/ https://ncbi.nlm.nih.gov/pubmed/28899930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201707540 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|